SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000819050-21-000031
Filing Date
2021-03-09
Accepted
2021-03-09 16:28:40
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 a20210309s3.htm S-3 480014
2 EX-1.2 a20210309s3exhibit12.htm EX-1.2 309365
3 EX-4.3 a20210309s3exhibit43.htm EX-4.3 564297
4 EX-4.4 a20210309s3exhibit44.htm EX-4.4 623721
5 EX-5.1 a20210309s3exhibit51.htm EX-5.1 53078
6 EX-23.1 a20210309s3exhibit231.htm EX-23.1 2909
7 fdlogo11.jpg GRAPHIC 12234
8 image_11.jpg GRAPHIC 20827
  Complete submission text file 0000819050-21-000031.txt   2080149
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254037 | Film No.: 21726206
SIC: 2836 Biological Products, (No Diagnostic Substances)